Australia's largest stock trading and investment forum Australia's #1 stock forum

NSB

Click for more information

7.69%

3.6¢ neuroscientific biopharmaceuticals ltd

Potential 100 bagger Biotech missed by the market, page-1077

First 1077 Last

Share
Profile

Follow
Popeye82

22,370 Posts.

485

03/09/21

00:44

Post #: 55796495
Share

Originally posted by KingHoves: ↑

@Popeye82 No I don't work in the area - I workin Finance. No one on this thread seems to have scientific background, Irely mostly on what the company says. For me, that it is modelled on somethingnaturally occurring in the human body, and the safety profile of peptides (asdetailed in the prospectus) and many company statements have said its safe andwell tolerated at high levels. What it will do in humans? Who knows. But my betis that because this is already occurring in our immune system, turbocharged, that it will be a success. IMO we are in the quiet before thestorm. I like to be early, but I am not patient.. Once these 4 Ph2 trialskick off, we will be straight to the races. Biggest risk from here is ifmanagement can re-write their history of missing deadlines and start to deliverOTIF. & thanks re IHL, those two posters I baited in my last post played nosmall part in that, they are next level and I hope our forum can attractposters of their caliber.

Goodluck

Expand

Hey,

If you would have to say:

Can you say Any Probability, from your Perspective, how probably NSB "will gonna be a Success" ??
For Exaaaaample "70/30", they will become a Success.
Something like...........

I am NOT searching "Guarantees", just Opinions.

NSB Price at posting: 31.5¢ Sentiment: Buy Disclosure: Not Held
Upvote

0 Great analysis

Reply

Top Stories

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

DEG

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

The winners & losers on market if negative gearing were gone

Week 39 Wrap: What HotCopper’s watching; China’s new stimmy moves boost metals; Oz CPI drop

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

There are more pages in this discussion • 442 more messages in this thread...

First 1077 Last

Add NSB (ASX) to my watchlist

(20min delay)
Last 3.6¢		Change -0.003(7.69%)		Mkt cap ! $5.350M

Open	High	Low	Value	Volume
3.7¢	3.7¢	3.6¢	$8.931K	246.4K

Buyers (Bids)

No.	Vol.	Price($)
2	200000	3.4¢

Sellers (Offers)

Price($)	Vol.	No.
3.6¢	246848	1

View Market Depth

No.	Vol.	Price($)
1	40	0.037
1	175000	0.036
1	57147	0.035
1	100000	0.034
3	163333	0.033

Price($)	Vol.	No.
0.038	12035	2
0.039	8986	2
0.040	50000	1
0.041	200000	1
0.043	40000	1

Last trade - 15.32pm 27/09/2024 (20 minute delay)

NSB (ASX) Chart